Fabio Bonelli

Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection

Vincenzo Summa, Alessia Petrocchi, Fabio Bonelli et al. · Journal of Medicinal Chemistry · 2008 · 624 citations · Full text

Antiviral Drug, Medicinal Chemistry, Antiviral Drug Development +16

Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency

Paolo Ingallinella, Elisabetta Bianchi, Neal A. Ladwa et al. · Proceedings of the National Academy of Sciences · 2009 · 209 citations · Full text

Antiviral Potency, Heptad Repeat 2, Antiviral Compound +15

A novel strategy for reducing phospholipids-based matrix effect in LC–ESI-MS bioanalysis by means of HybridSPE

Vincenzo Pucci, Serena Di Palma, Anna B. Alfieri et al. · Journal of Pharmaceutical and Biomedical Analysis · 2009 · 150 citations

Lipid Analysis, Lc–esi-ms Bioanalysis, Engineering +11

Potent Inhibitors of Subgenomic Hepatitis C Virus RNA Replication through Optimization of Indole-<i>N</i>-Acetamide Allosteric Inhibitors of the Viral NS5B Polymerase

Steven J. Harper, Salvatore Avolio, Barbara Pacini et al. · Journal of Medicinal Chemistry · 2005 · 86 citations · Full text

Crystal Structure, Viral Replication, Viral Polymerase Structure +21

A novel, inducible, eukaryotic gene expression system based on the quorum‐sensing transcription factor TraR

Petra Neddermann, Cesare Gargioli, Ester Muraglia et al. · EMBO Reports · 2003 · 80 citations · Full text

Transcriptional Regulation, Natural Sciences, Gene Regulation +8